EverPoint Asset Management’s Biogen BIIB Stock Holding History

EverPoint Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8.22M	Sell	29,000 -124,000	-81%	-$36.8M	0.15%	167
2016 Q3	$47.9M	Buy	+153,000	New	+$45.3M	0.86%	17
2016 Q2	–	Sell	-16,000	Closed	-$4.17M	–	387
2016 Q1	$4.17M	Sell	16,000 -115,000	-88%	-$30.4M	0.08%	252
2015 Q4	$40.1M	Buy	131,000 +112,000	+589%	+$32.2M	0.84%	15
2015 Q3	$5.54M	Buy	+19,000	New	+$6.27M	0.14%	198
2015 Q2	–	Sell	-35,000	Closed	-$14.8M	–	452
2015 Q1	$14.8M	Buy	35,000 +11,600	+50%	+$4.57M	0.28%	115
2014 Q4	$7.94M	Sell	23,400 -24,100	-51%	-$7.8M	0.18%	185
2014 Q3	$15.7M	Buy	47,500 +7,500	+19%	+$2.47M	0.36%	76
2014 Q2	$12.6M	Buy	+40,000	New	+$12M	0.26%	107

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EverPoint Asset Management's BIIB Position: Q4 2016 in Review

EverPoint Asset Management reduced its Biogen (BIIB) stake by 81% in Q4 2016, selling an estimated $36.8M and leaving 29,000 shares worth $8.22M. The position accounts for 0.15% of the portfolio, ranked #167.

EverPoint Asset Management first reported a position in BIIB in Q2 2014 and has held it in 9 quarters since. The position peaked at $47.9M in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

EverPoint Asset Management held 29,000 shares of Biogen worth $8.22M as of Q4 2016.
EverPoint Asset Management sold 124,000 Biogen shares in Q4 2016, an estimated $36.8M.
Biogen made up 0.15% of EverPoint Asset Management's portfolio in Q4 2016, its #167 holding.
EverPoint Asset Management first reported a position in Biogen in Q2 2014 and has held it in 9 quarters since.
EverPoint Asset Management's Biogen position peaked at $47.9M in Q3 2016.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.